“Rethinking regulatory for speed and efficiency”
Cory Wohlbach, Global Vice President Biosimilar Regulatory Affairs at Teva and Co-chair of the Biosimilar Forum. Recently spoke on behalf of the Association for Accessible Medicine’s Biosimilars Council about BsUFA III.
![“Rethinking regulatory for speed and efficiency”](/globalassets/biosimilars2/article-images/corystil-1280x720l.jpg)
Cory Wohlbach, Global Vice President Biosimilar Regulatory Affairs at Teva and Co-chair of the Biosimilar Forum
“Rethinking regulatory for speed and efficiency”